Now, it has been reported by analysts that the illegal imports could have involved cancer treatments Enhertu (trastuzumab deruxtecan), Imfinzi (durvalumab), or Imjudo (tremelimumab). Imfinzi was ...

Patritumab deruxtecan, which is currently leading the anti-HER3 pipeline, has shown efficacy in heavily pre-treated patients with EGFR-mutated NSCLC previously treated with multiple EGFR ...